ABOUT US

PolarCool AB (publ) is a medical device company that develops, markets, and sells products for sports medicine to teams, organizations and athletes. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.

POLARCAP® SYSTEM

PolarCap® System is intended to reduce brain temperature to prevent or limit long term cognitive impairment after brain trauma.

FASTER BRAIN RECOVERY.

RETURN TO PLAY - STATUS 3 WEEKS AFTER HEAD TRAUMA

Athletes treated with PolarCap® System have an almost 80% reduced risk of long-term absence, a statistically significant effect.

5 YEAR CLINICAL RESULTS

A clinical study performed by Lund University in collaboration with Swedish Hockey League (SHL) and HockeyAllsvenskan, during 2016-2021 showed that athletes treated with PolarCap® System returned to play faster.

PolarCool on Direkt Studios

PolarCools CEO, Erik Andersson, recently discussed the PolarCap System, PolarCools progress in 2021 and the companies plans for 2022 on Direkt Studios.

Topp 14: PolarCap, the cooling headcap that aims to limit brain injuries due to concussion

PolarCool AB (publ) momentum in the Top 14 of French Rugby, has been featured for an article by leading French newspaper, Le Parisien. The article highlights the PolarCap® System and PolarCools recent partnership with Stade Français Paris.